CD274 and melanoma: Additionally, the later phases of the trials on melanoma (compared to NSCLC, RCC, or urothelial carcinoma) were associated with increased cirAE incidence, while the treatment class (specifically PD-1 and PD-L1 blockade) was associated with lower cirAE incidence.